- Home
- CPIX vs BRNS Comparison
CPIX vs BRNS Comparison
Compare CPIX & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- BRNS
- Stock Information
- Founded
- CPIX 1999
- BRNS 2016
- Country
- CPIX United States
- BRNS United Kingdom
- Employees
- CPIX N/A
- BRNS N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- BRNS Health Care
- Exchange
- CPIX Nasdaq
- BRNS Nasdaq
- Market Cap
- CPIX 48.5M
- BRNS 48.3M
- IPO Year
- CPIX 2009
- BRNS 2021
- Fundamental
- Price
- CPIX $3.23
- BRNS $1.07
- Analyst Decision
- CPIX
- BRNS Strong Buy
- Analyst Count
- CPIX 0
- BRNS 1
- Target Price
- CPIX N/A
- BRNS $3.00
- AVG Volume (30 Days)
- CPIX 32.7K
- BRNS 42.9K
- Earning Date
- CPIX 11-06-2025
- BRNS 11-05-2025
- Dividend Yield
- CPIX N/A
- BRNS N/A
- EPS Growth
- CPIX N/A
- BRNS N/A
- EPS
- CPIX N/A
- BRNS N/A
- Revenue
- CPIX $42,071,813.00
- BRNS $14,969,000.00
- Revenue This Year
- CPIX N/A
- BRNS N/A
- Revenue Next Year
- CPIX N/A
- BRNS N/A
- P/E Ratio
- CPIX N/A
- BRNS N/A
- Revenue Growth
- CPIX 11.34
- BRNS 1766.46
- 52 Week Low
- CPIX $1.04
- BRNS $0.64
- 52 Week High
- CPIX $7.25
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- CPIX 43.51
- BRNS 41.80
- Support Level
- CPIX $3.26
- BRNS $1.08
- Resistance Level
- CPIX $3.57
- BRNS $1.20
- Average True Range (ATR)
- CPIX 0.20
- BRNS 0.10
- MACD
- CPIX -0.01
- BRNS -0.01
- Stochastic Oscillator
- CPIX 4.17
- BRNS 22.22
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.